Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Up – Here’s Why

Novozymes A/S (OTCMKTS:NVZMY)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $59.62, but opened at $62.25. Novozymes A/S shares last traded at $62.2355, with a volume of 934 shares changing hands.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on NVZMY. Kepler Capital Markets upgraded shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Rothschild & Co Redburn raised shares of Novozymes A/S to a “strong-buy” rating in a research report on Friday, March 27th. Finally, Zacks Research upgraded shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a research note on Monday, June 8th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy”.

Novozymes A/S Stock Performance

The company has a quick ratio of 1.03, a current ratio of 1.67 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $25.84 billion, a PE ratio of 42.11, a PEG ratio of 1.12 and a beta of 0.95. The company has a 50-day moving average price of $59.25 and a two-hundred day moving average price of $60.27.

Novozymes A/S (OTCMKTS:NVZMY) last issued its quarterly earnings data on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. Novozymes A/S had a return on equity of 6.52% and a net margin of 14.22%. Analysts predict that Novozymes A/S will post 2.43 EPS for the current fiscal year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).